Development and validation of a quantitative ELISA for the measurement of PSA concentration

Clinica Chimica Acta

Volumn 317, Issue 1-2, 2002, Pages 55-63

  Acevedo, Boris ^a   Perera, Yasser ^a   Ruiz, Miriam ^b   Rojas, Gertrudis ^a   Benítez, Jesús ^a   Ayala, Marta ^a   Gavilondo, Jorge ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b Isotopes Center   (Cuba)

Author keywords

ELISA; Equimolar detection; Monoclonal antibodies; PSA

Indexed keywords

MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ALGORITHM; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

ALPHA 1-ANTICHYMOTRYPSIN; ANIMALS; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MICE; MICE, INBRED BALB C; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0036156870     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00749-5     Document Type: Article

References (36)

1. Prostate-specific antigen in serum occurs predominantly in complex with alpha-1 antichymotrypsin
2. Individual prostate specific antigen (PSA) forms as prostate tumor markers
3. Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigen
4. The clinical usefulness of prostate specific antigen: Update
5. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges
6. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
7. Prostate-specific antigen: Current status
8. Prostate-specific antigen in prostatic carcinoma
9. Total and free PSA: A methodical and clinical evaluation of five assays
10. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the immulite immunochemiluminescent third-generation assay: Potential applications in prostate and breast cancers
11. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy
12. Bayer Immuno 1 PSA assay: An automated, ultrasensitive method to quantitate total PSA in serum
13. Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker
14. Prostate-specific antigen: Biochemistry, analytical methods, and clinical application
15. Use of lower prostate specific antigen cut-offs for prostate cancer screening in black and white men
16. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/ml. Prostate specific antigen
17. Editorial: New biological functions of prostate-specific antigen?
18. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines
19. Immunodiffusion and immunoelectrophoresis
20. 2b, immunoglobulins from mouse serum using protein A-sepharose
21. Determination of kinetic rate and equilibrium binding constants for macromolecular interactions: A critique of the surface plasmon resonance literature
22. Electrophoretic transfer of proteins from polyacrilamide gel to nitrocellulose sheets procedure and some applications
23. PSA standardization: A review of NCCLS, Stanford and Abbott efforts
24. Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bioblots
25. Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: Potential reference material for international standardization of PSA immunoassays
26. Epitope mapping on BIAcore: Theoretical and practical considerations
27. Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays
28. Detection of organ-confined prostate cancer is increased through prostate-specific antigen based-screening
29. Issues in the assessment of prostate-specific antigen immunoassays. An update
30. The clinical usefulness of prostate-specific antigen: Update 1994
31. Measurement of serum prostate specific antigen levels in females and in prostatectomized males with an ultrasensitive immunoassay technique
32. Issues on standardization of immunoassays for prostate-specific antigen: A review
33. Standardization of immunoassays for prostate specific antigen - A problem of prostate-specific antigen or a problem of assay design?
34. PSA standardization: A review of NCCLS, Stanford and Abbott efforts
35. Reference reagents for prostate specific antigen (PSA): Establishment of the first international standards for free PSA (90:10)